Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 25;45(3):268-74.
doi: 10.3785/j.issn.1008-9292.2016.05.08.

[Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus]

[Article in Chinese]
Yao Meifang  1 , Sun Xue  2 , Han Jue  2 , T U Yina  2 , H E Jie  2 , Zhao Yiming  2 , Lou Hanyu  2 , Pang Xiaohong  2 , Zeng Wenheng  2 , Zhang Songzhao  3 , Shan Pengfei  4
Affiliations

[Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus]

[Article in Chinese]
Yao Meifang et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. .

Abstract
in English, Chinese

Objective: To assess the impact of metabolic syndrome(MS) on Framingham risk score(FRS) in patients with type 2 diabetes mellitus (T2DM).

Methods: The anthropometric and biochemical data of 1708 patients with T2DM admitted in hospital from May 2008 to April 2013 were retrospectively analyzed, including 902 males and 806 females with a mean age of 57.1±11.8 years (20-79 years). Diagnosis of MS was made according to the criteria of the Adult Treatment Panel Ⅲ Criteria modified for Asians.

Results: Compared to non-MS/T2DM patients, MS/T2DM patients had higher waist circumference, body weight, body mass index, systolic and diastolic blood pressure, fasting C peptide, total cholesterol, triglyceride, and LDL-C (P<0.05), while lower HDL-C (P<0.01). Both FRS [13.0(10.0, 15.0) vs 11.0(9.0, 13.0) in male,15.0(12.0, 18.0) vs 12.0(6.0, 14.8) in female,P<0.01)] and 10-year cardiovascular risk [12.0%(6.0%, 20.0%) vs 8.0%(5.0%,12.0%) in male,3.0%(1.0%, 6.0%) vs 1.0%(0.0%, 2.8%) in female,P<0.01] were higher in MS/T2DM patients than those in non-MS/T2DM patients.Both FRS and 10-year cardiovascular risk were increased with the components of MS.

Conclusion: T2DM patients with MS have more cardiovascular risk factors, higher FRS and 10-year cardiovascular risk.

目的: 采用Framingham心血管危险评分（FRS）探讨2型糖尿病患者合并代谢综合征对10年心血管疾病风险的影响。

方法: 入选1708例于2008年5月至2013年4月在浙江大学医学院附属第二医院住院治疗的2型糖尿病患者，测定人体形态学和生化指标。采用ATPⅢ 2005亚洲标准诊断代谢综合征，按不同性别分为未合并代谢综合征组和合并代谢综合征组。

结果: 男女性2型糖尿病合并代谢综合征组腰围、体质量、体质指数、收缩压、舒张压、空腹c肽、总胆固醇、甘油三酯和低密度脂蛋白胆固醇均高于未合并代谢综合征组（均 P < 0.05），高密度脂蛋白胆固醇低于未合并代谢综合征组（ P < 0.01）。合并代谢综合征组FRS男性[13.0（10.0，15.0）与11.0（9.0，13.0）]、女性[15.0（12.0，18.0）与12.0（6.0，14.8）]和10年心血管风险男性[12.0%（6.0%，20.0%）与8%（5.0%，12.0%）]、女性[3.0%（1.0%，6.0%）与1.0%（0.0%，2.8%）]均高于未合并代谢综合征组（均 P < 0.01）。FRS和10年心血管风险随代谢综合征组分增加而增加。

结论: 2型糖尿病患者合并代谢综合征心血管危险因素增加，进一步增加FRS和10年心血管疾病风险。

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. KISHORE P, KIM S H, CRANDALL J P. Glycemic control and cardiovascular disease: what's a doctor to do? Curr Diab Rep. 2012;12(3):255–264. doi: 10.1007/s11892-012-0268-5. [KISHORE P, KIM S H, CRANDALL J P. Glycemic control and cardiovascular disease: what's a doctor to do?[J]. Curr Diab Rep, 2012, 12(3):255-264.] - DOI - PMC - PubMed
    1. 李 光伟. 关注血糖达标与低血糖风险之间的平衡——谈糖尿病合并心血管疾病的降血糖治疗. http://doi.med.wanfangdata.com.cn/10.3760/cma.j.issn.1000-6699.2012.01.001. 中华内分泌代谢杂志. 2012;28(1):1–3. [李光伟.关注血糖达标与低血糖风险之间的平衡——谈糖尿病合并心血管疾病的降血糖治疗[J].中华内分泌代谢杂志, 2012, 28(1):1-3.]
    1. YIN J H, SONG Z Y, SHAN P F, et al. Age-and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin Endocrinol (Oxf) 2012;76(6):802–809. doi: 10.1111/cen.2012.76.issue-6. [YIN J H, SONG Z Y, SHAN P F, et al. Age-and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China[J]. Clin Endocrinol (Oxf), 2012, 76(6): 802-809.] - DOI - PubMed
    1. BODEN-ALBALA B, SACCO R L, LEE H S, et al. Metabolic syndrome and ischemic stroke risk Northern Manhattan Study. Stroke. 2008;39(1):30–35. doi: 10.1161/STROKEAHA.107.496588. [BODEN-ALBALA B, SACCO R L, LEE H S, et al. Metabolic syndrome and ischemic stroke risk Northern Manhattan Study[J]. Stroke, 2008, 39(1): 30-35.] - DOI - PMC - PubMed
    1. RHEE S Y, PARK S Y, HWANG J K, et al. Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes: analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008. Diabetol Metab Syndr. 2014;6(1):98. doi: 10.1186/1758-5996-6-98. [RHEE S Y, PARK S Y, HWANG J K, et al. Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes: analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008[J]. Diabetol Metab Syndr, 2014, 6(1):98.] - DOI - PMC - PubMed